The class
A chiral CETP inhibitor binds the protein 5,000-fold more efficiently than its natural lipid substrate (Biochemistry 2000)
Original title: Stereospecific inhibition of CETP by chiral N,N-disubstituted trifluoro-3-amino-2-propanols
Chiral N,N-disubstituted trifluoro-3-amino-2-propanols were characterized as a class of stereospecific CETP inhibitors, each containing a single chiral centre essential for activity. The racemic mixture (R,S)SC-744 inhibited CETP-mediated cholesteryl ester transfer with an IC50 of 200 nanomolar in a reconstituted buffer system and 6 micromolar in plasma; upon separation, the (R,+) enantiomer SC-795 was about tenfold more potent (IC50 20 nanomolar, approaching the 8 nanomolar CETP concentration used), while the (S,-) enantiomer SC-794 had negligible activity, entirely explained by trace contamination with SC-795. These compounds associated with LDL and HDL without disrupting lipoprotein structure or CETP-HDL binding, did not affect phospholipid transfer protein or lecithin cholesterol acyltransferase activity, and competition and direct binding experiments showed SC-795 binds CETP with high affinity and specificity, roughly 5,000-fold more efficiently than the natural ligand cholesteryl ester, by reversibly and stereospecifically blocking the neutral lipid binding site.
Original abstract
Chiral N,N-disubstituted trifluoro-3-amino-2-propanols represent a recently discovered class of compounds that inhibit the neutral lipid transfer activity of cholesteryl ester transfer protein (CETP). These compounds all contain a single chiral center that is essential for inhibitory activity. (R,S)SC-744, which is composed of a mixture of the two enantiomers, inhibits CETP-mediated transfer of [(3)H]cholesteryl ester ([(3)H]CE) from HDL donor particles to LDL acceptor particles with an IC(50) = 200 nM when assayed using a reconstituted system in buffer and with an IC(50) = 6 microM when assayed in plasma. Upon isolation of the enantiomers, it was found that the (R,+) enantiomer, SC-795, was about 10-fold more potent than the mixture, and that the (S,-) enantiomer, SC-794, did not have significant inhibitory activity (IC(50) > 0.8 microM). All of the activity of the (S,-)SC-794 enantiomer could be accounted for by contamination of this sample with a residual 2% of the highly potent (R,+) enantiomer, SC-795. The IC(50) of (R,+)SC-795, 20 nM, approached the concentration of CETP (8 nM) in the buffer assay. These chiral N,N-disubstituted trifluoro-3-amino-2-propanols were found to associate with both LDL and HDL, but did not disrupt overall lipoprotein structure. They did not affect the on or off rates of CETP binding to HDL disk particles. Inhibition was highly specific since the activities of phospholipid transfer protein and lecithin cholesterol acyl transferase were not affected. Competition experiments showed that the more potent enantiomer (R)SC-795 prevented cholesteryl ester binding to CETP, and direct binding experiments demonstrated that this inhibitor bound to CETP with high affinity and specificity. It is estimated, based on the relative concentrations of inhibitor and lipid in the transfer assay, that (R)SC-795 binds approximately 5000-fold more efficiently to CETP than the natural ligand, cholesteryl ester. We conclude that these chiral N,N-disubstituted trifluoro-3-amino-2-propanol compounds do not affect lipoprotein structure or CETP-lipoprotein recognition, but inhibit lipid transfer by binding to CETP reversibly and stereospecifically at a site that competes with neutral lipid binding.
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.